| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/10/2001 | CN1316910A Composition and methods for regulating lymphocyte activation |
| 10/10/2001 | CN1316909A Liver function ameliorating agents |
| 10/10/2001 | CN1316908A Neuroprotection |
| 10/10/2001 | CN1316907A Remedies for apoptosis-associated diseases |
| 10/10/2001 | CN1316906A Stable liquid formulations of botulinum toxin |
| 10/10/2001 | CN1316903A Compositions and methods for treating and preventing bone diseases using tocotrienols |
| 10/10/2001 | CN1316901A The use of fumaric acid derivatives in transplant medicine |
| 10/10/2001 | CN1316435A Human testicular development specificity protein-8 gene coding protein |
| 10/10/2001 | CN1316434A Human specific protein kinase-15 gene coding protein |
| 10/10/2001 | CN1316433A Human exonuclease factor gene coding protein |
| 10/10/2001 | CN1316432A Cell death inhibitory albumen |
| 10/10/2001 | CN1316279A X-ray magnetic therapy machine for PDT therapy of cancer by combining radiatherapy with chemicotherapy and its medicine |
| 10/10/2001 | CN1316271A Chewing gum for preventing decayed tooth and its preparing process |
| 10/10/2001 | CN1072719C Isolated nucleic acid sequence coding for tumor rejection antigen precursor |
| 10/10/2001 | CN1072506C Improved diplococuus meninigitidis polysaccharide conjugate vaccine |
| 10/10/2001 | CN1072504C 肽的应用 Application peptide |
| 10/10/2001 | CN1072494C Medicinal liquor for treatment of osteoproliferation, muscular dystrophy and rheumatism |
| 10/10/2001 | CN1072491C Nutritive liquid for nourishing brain and promoting intelligence growth |
| 10/10/2001 | CA2302861A1 Signal peptides nucleic acid molecules and methods for treatment of caries |
| 10/09/2001 | WO2000066625A1 Soybean protein nutraceuticals |
| 10/09/2001 | US6300540 Genetically engineered rodent model; for use in diagnosis an treatment of alzheimer's disease |
| 10/09/2001 | US6300501 Histidine-(N-benzyl glycinamide) inhibitors of protein farnesyl transferase |
| 10/09/2001 | US6300492 Nucleotide sequences for the prevention of suppression of apoptosis and treatment lymphoma, leukemia, melanoma, ovarian, mammary gland, pancreatic and lung cancers |
| 10/09/2001 | US6300490 Expression vector coding cytosine deaminase; for use in the treatment of cancers |
| 10/09/2001 | US6300488 Modified lepidopteran receptors and hybrid multifunctional proteins for use in transcription and regulation of transgene expression |
| 10/09/2001 | US6300485 Myosin IXa and cyclic nucleotide gated channel-15 (CNGC-15) polynucleotides, polypeptides, compositions, methods, and uses thereof |
| 10/09/2001 | US6300483 Compositions inducing cleavage of RNA motifs |
| 10/09/2001 | US6300482 MDKI, a novel receptor tyrosine kinase |
| 10/09/2001 | US6300479 Immunoglobulins; for use in diagnosis and treatment of cancer |
| 10/09/2001 | US6300478 Polyclonal antibody; for treating cancer, viral infections and bacterial infections |
| 10/09/2001 | US6300477 Preferential immunoglobulin; for use in treatment of arthritis; for prevention of bacterial and viral infection; for use in gene therapy |
| 10/09/2001 | US6300475 Interferon PRO655 |
| 10/09/2001 | US6300474 Modified interferons |
| 10/09/2001 | US6300472 Rab proteins |
| 10/09/2001 | US6300471 FSH-releasing peptides |
| 10/09/2001 | US6300470 Amino acid sequence for the treatment of inflammatory pathology; microbiocides |
| 10/09/2001 | US6300337 Acetamide derivative and use thereof |
| 10/09/2001 | US6300322 Water solution with hydroxyethyl starch, sodium ion, chloride ion, potassium iion and calcium ion for plasma substitution |
| 10/09/2001 | US6300320 Modulation of c-jun using inhibitors of protein kinase C |
| 10/09/2001 | US6300318 Antibacterial and antibiotic methods using peptide nucleic acids and pharmaceutical compositions therefor |
| 10/09/2001 | US6300317 Eukarotic cells, polynucleotide, functional agents, membrane permeability, subcellar localization agents and polynucleotide masking agents |
| 10/09/2001 | US6300315 Mineralized collagen membrane and method of making same |
| 10/09/2001 | US6300314 Admnistering heterocyclic peptides to stimulate hematopoiesis of cells |
| 10/09/2001 | US6300313 Means for treating prostate hypertrophy and prostate cancer |
| 10/09/2001 | US6300312 Prostaglandin receptor antagonist binding to intracellular molecular interfaces |
| 10/09/2001 | US6300311 Administering epidermal growth factor to pigs to increase litter size |
| 10/09/2001 | US6300310 Amino acid sequence with segments of polypeptides |
| 10/09/2001 | US6300309 Treatment of osteoporosis in mamals with reduced cortical bone mineral density |
| 10/09/2001 | US6300132 Antisense inhibition of telomeric repeat binding factor 2 expression |
| 10/09/2001 | US6300129 Transgenic non-human animals for producing heterologous antibodies |
| 10/09/2001 | US6300127 Bone mineralization proteins, DNA, vectors, expression systems |
| 10/09/2001 | US6300111 A dna encoding a polypeptide; diagnosis and therapy for cancer, atherosclerosis and the responses of tissues to injury |
| 10/09/2001 | US6300110 A recombinant peptide for regulating telomere length and modulating telomerase activity; detection, diagnosis and therapy of cellular proliferative diseases, cancer and aging |
| 10/09/2001 | US6300104 Producing large quantities of secretory immunoglobulin a molecules by transfecting a single cell type with an immunoglobulin containing a polynucleotide encoding a secretory component; collecting, purifying supernatant |
| 10/09/2001 | US6300097 A polypeptide; therapy and diagnosis of bacterial infections; upper respiratory infections, toxic shock syndrome, septic arthritis and intestinal disorders |
| 10/09/2001 | US6300094 Polynucleotides encoding a novel ABC transporter |
| 10/09/2001 | US6300093 Islet cell antigen 1851 |
| 10/09/2001 | US6300092 Methods of use of a novel lysyl oxidase-related protein |
| 10/09/2001 | US6300089 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus |
| 10/09/2001 | US6300087 A screening method to determine drugs that bind to human serotonin receptors by exposing nonneuronal cells expressing the serotonin receptor on their surface with a plurality of drugs; determine which drugs interact by binding |
| 10/09/2001 | US6300086 Transform cells with polynucleotides encoding ligand protein and domain proteins with a reporter gene whose expression is regulated by ligands binding the domain protein; culture cells with/without agent, measure expression based on binding |
| 10/09/2001 | US6300080 Screening molecular libraries to identify lead drug compounds that modulate adhesion between lymphocytes and cadherin expressing cells by performing adhesion assays with and without one molecular library member and compare results |
| 10/09/2001 | US6300067 TFIIB transcription factor from Candida albicans and methods of screening for inhibitors of Candida albicans growth |
| 10/09/2001 | US6300062 Enamel matrix related polypeptide |
| 10/09/2001 | US6300059 Testing tissue sample to determime the expression levels of mrna or protein encoded by a p53 mediator, waf1, and compare values to normal tissue; diagnosis and therapy of human tumors, cancer therapy |
| 10/09/2001 | US6299911 Foods, drugs |
| 10/09/2001 | US6299898 Methods and compositions for the treatment of wounds |
| 10/09/2001 | US6299893 Method to reduce hair loss and stimulate hair regrowth |
| 10/09/2001 | US6299883 Tarf |
| 10/09/2001 | US6299879 Methods of immunization by administering fibrinogen binding protein or fragments thereof |
| 10/09/2001 | US6299878 Immunosuppressing mammal; administering pooled transferrin-derived glycans from mammal which are free of transferrin polypeptide moieties; grafting foreign cells or tissues to controll immune response |
| 10/09/2001 | US6299877 Used in therapy |
| 10/09/2001 | US6299876 Cytotoxic drug therapy |
| 10/09/2001 | US6299875 Methods to block IGE binding to cell surface receptors of mast cells |
| 10/09/2001 | US6299874 Administering vaccine conjugate consisting essentially of a live virus and a neutralizing factor bound to live virus; neutralizing factor is selected from the group consisting of antibodies and antibody fragments |
| 10/09/2001 | US6299872 Administering combination of interferon alpha and ribavirin to reduce symptoms of hepatitis c infection |
| 10/09/2001 | US6299871 Orally-administrable therapeutic and/or prophylactic agent for HTLV-1-related diseases |
| 10/09/2001 | US6299870 Has antiviral activity, antitumor activity, growth inhibition activity and immunosupressive activity; used in therapy |
| 10/09/2001 | US6299869 Human interferon-epsilon: a type I interferon |
| 10/09/2001 | US6299067 Bar code scanner with intuitive head aiming and collimated scan volume |
| 10/09/2001 | CA2235025C Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 10/09/2001 | CA2222296C Peptide and method of obtaining it |
| 10/09/2001 | CA2123223C Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
| 10/09/2001 | CA1341303C Lymphokine activated effector cells for antibody-dependent cellular cytotoxicity (adcc) treatment of cancer and other diseases |
| 10/09/2001 | CA1341301C Preparation of functional human urokinase proteins |
| 10/07/2001 | CA2340936A1 Inhibitors for the formation of soluble human cd23 |
| 10/04/2001 | WO2001073435A1 Methods for detecting inflammation and inflammatory conditions |
| 10/04/2001 | WO2001073133A1 Compositions and methods for identifying and targeting cancer cells |
| 10/04/2001 | WO2001073132A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 10/04/2001 | WO2001073131A1 High specificity marker detection |
| 10/04/2001 | WO2001073093A2 Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| 10/04/2001 | WO2001073077A2 Regulation of human serine racemase enzyme |
| 10/04/2001 | WO2001073076A2 Helicase inhibitors |
| 10/04/2001 | WO2001073070A1 Novel polypeptide--- a rjs related protein 94 and polynucleotide encoding it |
| 10/04/2001 | WO2001073066A1 A novel polypeptide, a human atp dependent serine hydrolase 10.1 and the polynucleotide encoding the polypeptide |
| 10/04/2001 | WO2001073063A1 Novel polypeptide---a human hexose kinase 13 and polynucleotide encoding it |
| 10/04/2001 | WO2001073061A1 Novel polypeptide - a human retinoblastoma protein 22 and polynucleotide encoding it |
| 10/04/2001 | WO2001073060A2 18221, dual specificity phosphatase and uses thereof |
| 10/04/2001 | WO2001073059A2 38692 and 21117: dual specificity phosphatase molecules and uses therefor |
| 10/04/2001 | WO2001073057A1 19053, a novel atpase-like molecule and uses thereof |